The Veteran's lung cancer residuals are denied for initial compensable ratings prior to January 18, 2017, and a rating in excess of 10 percent from January 18, 2017 to January 24, 2020. A rating in excess of 30 percent after January 24, 2020 is also denied.
The deciding factor: The Veteran did not meet the criteria for a compensable or higher rating based on his FEV-1 and FEV-1/FVC levels during the appeal period.
- Claimed conditions
- lung cancer residuals
- How they argued it
- Direct service connection
- Exposure basis
- None
- Rating
- Not verified here — check the original decision
- Decision date
- November 22, 2023
- Citation
- 23062123
This is a plain-language summary generated by AI from a public Board of Veterans’ Appeals decision. It can contain errors — always verify against the original. Read the original VA decision (opens in a new tab) using citation 23062123.
What this means for you
A final Board denial may be appealed to the U.S. Court of Appeals for Veterans Claims, generally within 120 days of the Board mailing date. A Supplemental Claim with new and relevant evidence is a separate option. Another Higher-Level Review of the Board decision is not available. Check your own notice: this historical decision does not set your deadline.
What you can do next
Use your own notice and decision stage. A remanded issue is not a final court-appealable denial. VA review guidance and CAVC filing instructions (U.S. federal; reviewed October 7, 2026).
Related decisions
Other Board decisions on a similar condition or argued the same way.
- Whole decision: Remanded (sent back)
The Board has determined that the VA medical opinions are inadequate and remands the case for further clarification on whether the Veteran's service-connected disabilities have caused or aggravated his obstructive sleep apnea, including obesity.
- Whole decision: Remanded (sent back)
The Board has remanded the claims of service connection for prostate cancer residuals and lung cancer residuals due to procedural errors in the August 2022 rating decision.
- Whole decision: Partly granted
The 100 percent rating for lung cancer was discontinued effective November 1, 2024, as the Veteran's lung cancer is in remission and no longer active. The claim for a compensable disability rating for lung cancer residuals has been remanded.
- Whole decision: Denied
The Board denied service connection for lung cancer residuals, Parkinson's disease, neuropathy in the right and left lower extremities due to herbicide exposure, as well as special monthly compensation based on aid and attendance.
Free starter guide for your own claim
Reading this because you were denied or under-rated? Get the plain-English next steps — your appeal options, the deadline that protects you, and how appeals like yours turn out. One email, no spam.
We will only use this to send the guide. No spam, unsubscribe any time. We never sell your information.
We are not the VA. Veterans’ Rights is an independent resource built for veterans. We are not the U.S. Department of Veterans Affairs, not part of the government, and not endorsed by any government agency.
This is general information, not legal advice. For advice about your own situation, talk to a VA-accredited representative — many help for free.